InvestorsHub Logo
Followers 7
Posts 117
Boards Moderated 0
Alias Born 02/16/2020

Re: None

Saturday, 09/12/2020 9:37:43 PM

Saturday, September 12, 2020 9:37:43 PM

Post# of 425912
Salt to the wounds.

Gilead Sciences Inc. (NASDAQ: GILD) is gearing up to purchase drug innovator Immunomedics Inc. (NASDAQ: IMMU) for a price tag exceeding $20 billion.

https://finance.yahoo.com/news/report-gilead-sciences-cancer-treatment-222217580.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News